Home > Insider Trading > Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals Inc. (ARWR)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
21 - 30
Next >>

Hedge Funds Are Piling Into Arrowhead Pharmaceuticals Inc. (ARWR)

Our extensive research has shown that imitating the smart money can generate significant returns for retail investors, which is why we track nearly 900 active prominent money managers and analyze their...

Keep Reading →

October 18th, 2021 - Hedge Funds News

Is Arrowhead Pharmaceuticals (ARWR) A Good Stock To Buy Now?

Baron Opportunity Fund recently published its second-quarter commentary – a copy of which can be downloaded here.

Keep Reading →

August 27th, 2021 - Hedge Fund Investor Letters News

Here is What Hedge Funds Think About Arrowhead Pharmaceuticals Inc. (ARWR)

The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.

Keep Reading →

July 21st, 2021 - Hedge Funds News

Is Arrowhead Pharmaceuticals (ARWR) A Smart Long-Term Buy?

Baron Funds, an asset management firm, published its “Baron Opportunity Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

May 3rd, 2021 - Hedge Fund Investor Letters News

Should You Retain Your Arrowhead Pharmaceuticals (ARWR) Position?

Baron Funds, an asset management firm, published its “Baron Health Care Fund” first quarter 2021 investor letter – a copy of which can be downloaded here.

Keep Reading →

April 30th, 2021 - Hedge Fund Investor Letters News

Is ARWR Stock A Buy or Sell?

We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors...

Keep Reading →

April 26th, 2021 - Hedge Funds News

Is Arrowhead Pharmaceuticals (ARWR) Stock a Buy For 2021?

Baron Health Care Fund recently published its fourth-quarter commentary – a copy of which can be downloaded here.

Keep Reading →

February 17th, 2021 - Hedge Fund Investor Letters News

Is ARWR A Good Stock To Buy Now According To Hedge Funds?

The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the third quarter, which unveil their equity positions as of September...

Keep Reading →

December 19th, 2020 - Hedge Funds News

Hedge Fund and Insider Trading News: Mike Novogratz, Crispin Odey, Steve Cohen, Fulcrum Asset Management, Elliott Management, Envestnet Inc (ENV), Arrowhead Pharmaceuticals Inc (ARWR), and More

Bitcoin is like "digital gold" and won't be used in the same way as traditional currency for at least the next five years, billionaire investor Mike Novogratz told Bloomberg on Friday.

Keep Reading →

October 26th, 2020 - Hedge Funds Insider Trading

Hedge Fund and Insider Trading News: Ray Dalio, Balyasny Asset Management, Asia Research and Capital Management, Alcur Select, Lam Research Corporation (LRCX), Enghouse Systems Limited (EGHSF), and More

Bridgewater Associates founder Ray Dalio is giving $50 million to NewYork-Presbyterian to fight health inequality at a time when the coronavirus pandemic has laid bare the disproportionate access to health...

Keep Reading →

October 14th, 2020 - Hedge Funds Insider Trading